基于网络药理学的马齿苋治疗动脉粥样硬化作用机制研究
Study on Mechanism of Portulacae Herba in Treatment of Atherosclerosis Based on Network Pharmacology
DOI: 10.12677/TCM.2021.103060, PDF,    科研立项经费支持
作者: 王 霞, 高 强:宁夏医科大学临床医学院,宁夏 银川;尚 猛:宁夏医科大学公共卫生与管理学院,宁夏 银川;孙绍庆:宁夏医科大学口腔医学院,宁夏 银川;曲添星:宁夏医科大学药学院,宁夏 银川;中国海洋大学医药学院,山东 青岛;陆钊罡:宁夏回族自治区人民医院/西北民族大学第一附属医院药学部,宁夏 银川;王 锐*:宁夏医科大学药学院,宁夏 银川;宁夏特色中医药现代化工程技术研究中心,宁夏 银川;宁夏医科大学回医药现代化教育部重点实验室,宁夏 银川;西南医科大学心血管医学研究所,医学电生理教育部重点实验室,四川 泸州
关键词: 马齿苋动脉粥样硬化网络药理学分子对接Portulacae Herba Atherosclerosis Network Pharmacology Molecular Docking
摘要: 目的:基于网络药理学方法探究马齿苋治疗动脉粥样硬化的作用机制。方法:通过TCMSP (Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform)数据库获取马齿苋的活性成分及作用靶点,根据ADME筛选其主要活性成分,通过String平台进行分析并利用Cytoscape3.7.2软件构建马齿苋主要活性成分与作用靶点的网络;收集Disgenet、OMIM、Drugbank数据库中动脉粥样硬化的靶点,通过String平台进行马齿苋与动脉粥样硬化共同靶点相互作用分析并利用Cytoscape3.7.2软件构建其PPI网络;采用Metascape平台进行“药物–成分–靶点”的基因功能与通路分析,通过CB-DOCK进行分子对接验证。结果:马齿苋的主要活性成分为槲皮素、山柰酚、木犀草素等10个,对应212个作用靶点。动脉粥样硬化有关的靶点1081个。马齿苋成分–动脉粥样硬化共同靶点有ALB、IL-6、TNF等108个,主要通路有流体剪切力与动脉粥样硬化途径、癌症的途径、TNF信号通路等。槲皮素、山柰酚、木犀草素分别与ALB、IL-6的对接得分均< −5 kcal/mol,说明它们之间的分子对接能力均较好。结论:马齿苋通过多成分、多靶点、多通路参与动脉粥样硬化的调节。
Abstract: Objective: To analyze the mechanism of Portulacae Herba in the treatment of atherosclerosis based on network pharmacological method. Methods: The active components and action targets of Portulacae Herba were obtained from TCMSP (Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform) Database, and the main active components of TCM were screened according to ADME. The String platform was used for analysis, and Cytoscape3.7.2 software was used to construct the network of main active components and action targets of purslane. The main atherosclerosis targets were collected from Disgenet, OMIM and DRUGBank databases. Protein interaction analysis was performed on the String platform, and a PPI network of common targets of Portulacae Herba and atherosclerosis was constructed using Cytoscape3.7.2 software. Metascape platform was used to analyze the gene function and pathway of “drug-component-target”, and finally CB-dock was used for molecular docking verification. Results: The main active components of Portulacae Herba in the treatment of atherosclerosis were 10, including quercetin, kaempferol and luteolin, corresponding to 212 targets. There were 1081 targets associated with atherosclerosis. Portulacae Herba ingredients - common targets of atherosclerosis has propagated, IL-6, TNF, such as 108. The main pathways have fluid shear stress and atherosclerosis, cancer pathway, TNF signaling pathway and so on. The docking scores of quercetin, kaempferol and luteolin with ALB and IL-6 were all < −5 kcal/mol, indicating that the molecular docking ability between them was good. Conclusion: Portulacae Herba is involved in the regulation of atherosclerosis through multi-component, multi-target and multi-pathway.
文章引用:王霞, 尚猛, 孙绍庆, 高强, 曲添星, 陆钊罡, 王锐. 基于网络药理学的马齿苋治疗动脉粥样硬化作用机制研究[J]. 中医学, 2021, 10(3): 427-439. https://doi.org/10.12677/TCM.2021.103060

参考文献

[1] Zhu, Y.H., Xian, X.M., Wang, Z.Z., Bi, Y.C., Chen, Q.G., Han, X.F., et al. (2018) Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules, 8, Article No. 80. [Google Scholar] [CrossRef] [PubMed]
[2] Ruiz-León, A.M., Lapuente, M., Estruch, R. and Casas, R. (2019) Clinical Advances in Immunonutrition and Atherosclerosis: A Review. Frontiers in Immunology, 10, Article No. 837. [Google Scholar] [CrossRef] [PubMed]
[3] 孔涛. 适合中国低收入人群高血压药物治疗方案的探索[D]: [博士学位论文]. 北京: 北京协和医学院, 2019.
[4] Simic, I. and Reiner, Z. (2015) Adverse Effects of Sta-tins—Myths and Reality. Current Pharmaceutical Design, 21, 1220-1226. [Google Scholar] [CrossRef] [PubMed]
[5] Zhou, Y.X., Xin, H.L., Khalid, R., Wang, S.-J., Peng, C. and Zhang, H. (2015) Portulaca oleracea L.: A Review of Phytochemistry and Pharmacological Effects. Journal of Biomedicine and Biotechnology, 2015, Article ID: 925631. [Google Scholar] [CrossRef] [PubMed]
[6] Parham, S., Kharazi, A.Z., Bakhsheshi-Rad, H.R., Nur, H., Ismail, A.F., Sharif, S., et al. (2020) Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials. Antioxidants, 9, Article No. 1309. [Google Scholar] [CrossRef] [PubMed]
[7] 赵仁宏, 赵心童, 贺圣文, 贺圣光, 王守训, 邵丽军. 马齿苋脂肪油对动脉粥样硬化大鼠胆固醇逆向转运相关基因表达的影响[J]. 中国慢性病预防与控制, 2013, 21(1): 12-14.
[8] 魏亚男, 朱博冉, 姬梦姣, 周童, 翟意, 薛文达, 等. 基于网络药理学探究补阳还五汤防治动脉粥样硬化的作用机制[J]. 中国药理学通报, 2020, 36(12): 1750-1755.
[9] 戚明珠, 张铌雪, 苏晓慧, 孔祥英. 黄芪甲苷治疗缺血性脑卒中的网络药理学[J]. 中国实验方剂学杂志, 2021, 27(3): 163-170.
[10] 段贤春, 黄石, 彭代银, 韩岚, 汪小莉, 汪永忠, 潘凌宇. 网络药理学在中药复方研究中的应用[J]. 中国药理学通报, 2020, 36(3): 303-308.
[11] Li, S. and Zhang, B. (2013) Traditional Chinese Medicine Network Pharmacology: Theory, Methodology and Application. Chinese Journal of Natural Medicines, 11, 110-120. [Google Scholar] [CrossRef
[12] 李大鹏, 江杨, 李锋, 孙东晓. 槲皮素通过ceRNA调控PTEN/PI3K/AKT信号通路干预Ox-LDL诱导的HUVECs氧化应激损伤[C]//中国食品科学技术学会. 中国食品科学技术学会第十七届年会论文集. 中国食品科学技术学会, 2020: 211-212.
[13] Patel, R.V., Mistry, B.M., Shinde, S.K., Syed, R., Singh, V. and Shin, H.-S., (2018) Therapeutic Potential of Quercetin as a Cardiovascular Agent. European Journal of Medicinal Chemistry, 155, 889-904. [Google Scholar] [CrossRef] [PubMed]
[14] Li, X.-Y., Kong, L.-X., Li, J., He, H.-X. and Zhou, Y.-D. (2013) Kaempferol Suppresses Lipid Accumulation in Macrophages through the Downregulation of Cluster of Differentiation36 and the Upregulation of Scavenger Receptor Class B Type I and ATP-Binding Cassette Transporters A1 and G1. International Journal of Molecular Medicine, 31, 331-338. [Google Scholar] [CrossRef] [PubMed]
[15] Ding, X., Zheng, L., Yang, B., Wang, X. and Ying, Y. (2019) Luteolin Attenuates Atherosclerosis via Modulating Signal Transducer And Activator of Transcription 3-Mediated Inflammatory Response. Drug Design, Development and Therapy, 13, 3899-3911. [Google Scholar] [CrossRef
[16] Adly, A.A.M., ElSherif, N.H.K., Ismail, E.A.R., Ibrahim, Y.A., Niazi, G. and Elmetwally, S.H. (2017) Ischemia-Modified Albumin as a Marker of Vascular Dysfunction and Subclinical Atherosclerosis in β-Thalassemia Major. Redox Report, 22, 430-438. [Google Scholar] [CrossRef] [PubMed]
[17] Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K., Schieffer, B. (2009) How Much Is too Much? Interleukin-6 and Its Signalling in Atherosclerosis. Thrombosis & Haemostasis, 101, 215-222. [Google Scholar] [CrossRef
[18] Bartekova, M., Radosinska, J., Jelemensky, M. and Dhalla, N.S. (2018) Role of Cytokines and Inflammation in Heart Function during Health and Disease. Heart Failure Reviews, 23, 733-758. [Google Scholar] [CrossRef] [PubMed]
[19] Cunningham, K.S. and Gotlieb, A.I. (2005) The Role of Shear Stress in the Pathogenesis of Atherosclerosis. Laboratory Investigation, 85, 9-23. [Google Scholar] [CrossRef] [PubMed]
[20] Balzan, S. and Lubrano, V. (2018) LOX-1 Receptor: A Potential Link in Atherosclerosis and Cancer. Life Sciences, 198, 79-86. [Google Scholar] [CrossRef] [PubMed]
[21] Gao, W., Liu, H., Yuan, J., Wu, C., Huang, D., Ma, Y., et al. (2016) Exosomes Derived from Mature Dendritic Cells Increase Endothelial Inflammation and Atherosclerosis via Membrane TNF-α Mediated NF-κB Pathway. Journal of Cellular & Molecular Medicine, 20, 2318-2327. [Google Scholar] [CrossRef] [PubMed]